🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3, randomized, placebo-controlled, double masked, parallel ...
Status
Completed
Location
American Genomics Site 2
Start Date
2021-03-30
Trial ID
NCT04829344
The objectives of this study are: * To evaluate the efficacy of Nyxol (phe...
Status
Completed
Location
Kannar Eye Care
Start Date
2019-08-13
Trial ID
NCT04024891
Thymosin Beta 4 (Tβ4) is a synthetic copy of the naturally-occurring 43-ami...
Status
Completed
Location
Multiple Locations
Start Date
2011-08
Trial ID
NCT01387347
Treatments Being Tested
Corticosteroids are substances produced by the adrenal gland to help the bo...
Status
Completed
Location
Rutgers-RWJMS
Start Date
2010-02
Trial ID
NCT01064986
The objectives of this study are: To evaluate the efficacy of Nyxol + Pilo...
Status
Completed
Location
Clinical Site 12
Start Date
2021-02-15
Trial ID
NCT04675151
Treatments Being Tested
The objectives of this study are: * To evaluate the efficacy of Nyxol to i...
Status
Completed
Location
Clinical Site 6
Start Date
2020-12-30
Trial ID
NCT04638660
Treatments Being Tested
A phase 2a multicenter, randomized, double-blinded, placebo-controlled clin...
Status
Completed
Location
Achilles Foot Health Centre
Start Date
2023-08-02
Trial ID
NCT05877313
Treatments Being Tested
This is a Phase 3, randomized, placebo-controlled, double masked, parallel ...
Status
Completed
Location
American Genomics Site 1
Start Date
2020-09-03
Trial ID
NCT04513652
Lesions of herpes labialis are caused by the herpes simplex virus type 1 (H...
Status
Completed
Location
Anna Carolina R.T. Horliana
Start Date
2020-01-01
Trial ID
NCT04037475
Treatments Being Tested
The objectives of this study are: * To evaluate the efficacy of Nyxol to e...
Status
Completed
Location
Clinical Site 11
Start Date
2020-11-18
Trial ID
NCT04620213
Treatments Being Tested